It dosen't matter if it holds 8 or stays green today, because without further news it'll go down tomorrow.
To get this stock really moving up it needs great news, like Maurie Hill reporting improved vision in her treated eye.
The average time per patient to start seeing results is around three weeks. Maurie was treated ages ago. While we all would love for her to one day see again, she's had the disease for a very long time. That's why she was included in the safety trial. As Rabin stated in the recent interview, their ultimate target audience is those patients who are very early in the disease, because in those patients the photoreceptors aren't dead, they're just dormant.
Nobody wants to forget about Maurie but she isn't isn't the type of patient that this treatment was made for. The earlier-stage patients that are being treated will have a better chance of seeing concrete and measurable results. That's the great news you should be keeping your eyes on.